← All companies
Kymera Therapeutics, Inc.
KYMR - CIK 0001815442
Market cap$6.80 B
Rank#1180
SEC filings575
The table below shows Kymera Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $144.09M | $112.95M | $335.82M | $89.97M | $110.72M | $67.61M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | $40.00M | - | $0.00 | $0.00 |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.